Results 21 to 30 of about 17,612 (170)

Essential thrombocythemia, hemolytic anemia and hepatic cirrhosis: Could there be an association?

Hematology Reports, 2018
Vascular events are the most common clinical complication of essential thrombocythemia, leading to sign and symptoms of this disease. There are various sign and symptoms of essential thrombocythemia, such as thrombosis in artery or vein, and enlarged ...
Nata Pratama Hardjo Lugito, Andree Kurniawan, Yohanes Chandra Kurniawan, Enny Yacobus, Edwin Halim   +4 more
doaj   +1 more source

Cold Agglutinin-induced Hemolytic Anemia as the Primary Presentation in Systematic Lupus Erythematosus (SLE) in Pregnancy Triggered by Infection: A Case Report

Case Reports in Clinical Practice, 2022
Autoimmune hemolytic anemia (AIHA) may be the first manifestation of systematic lupus erythematosus (SLE). Antierythrocyte antibodies in SLE are mainly warm-type Immunoglobulin G (IgG), but mixed-type AIHA is also reported.
Vajihe Marsusi, Ashraf Sadat Jamal, Laleh Eslamian, Maasoumeh Saleh, Behnaz Nouri, Danial Dehghan   +5 more
doaj  

Hemolytic Anemias: Autoimmune and Beyond

Journal of the Advanced Practitioner in Oncology, 2021
During JADPRO Live Virtual 2020, Ravi Krishnadasan, MD, FACP, provided an overview of the terminology of hemolysis, laboratory tests used in the diagnosis of hemolytic anemias, and appropriate indications for treatment of the various hemolytic anemias.
openaire   +4 more sources

Non-immune Hemolysis in Gaucher Disease and Review of the Literature Eliyakim Hershkop, Idan Bergman, Alina Kurolap, Najib Dally, and Hagit Baris Feld

Rambam Maimonides Medical Journal, 2021
Gaucher disease (GD) is an autosomal recessive disease characterized by the buildup of glucocerebrosides in macrophages, resulting in the formation of “Gaucher cells.” These cells predominantly infiltrate the liver, spleen, and bone marrow leading to ...
Eliyakim Hershkop, Idan Bergman, Alina Kurolap, Najib Dally, Hagit Baris Feldman   +4 more
doaj   +1 more source

Bortezomib in autoimmune hemolytic anemia and beyond [PDF]

Therapeutic Advances in Hematology, 2021
Bortezomib is a first-in-class, potent, selective and reversible proteasome inhibitor approved for the treatment of multiple myeloma (MM) and relapsed/refractory mantle cell lymphoma. In these diseases, bortezomib targets plasma cells and lymphocytes reducing tumor burden.
Pasquale R., Giannotta J. A., Barcellini W., Fattizzo B.   +3 more
openaire   +4 more sources

Vitamin B12 and vitamin D deficiencies: An unusual cause of fever, severe hemolytic anemia and thrombocytopenia

Journal of Family Medicine and Primary Care, 2015
The array of diagnostic workup for pyrexia of unknown origin (PUO) generally revolves in searching for infections, inflammatory/autoimmune, and endocrine etiologies.
Vikas A Mishra, Rishit Harbada, Akhilesh Sharma   +2 more
doaj   +1 more source

Development of New Drugs for Autoimmune Hemolytic Anemia

Pharmaceutics, 2022
Autoimmune hemolytic anemia (AIHA) is a rare disorder characterized by the autoantibody-mediated destruction of red blood cells, and treatments for it still remain challenging.
Zhengrui Xiao, Irina Murakhovskaya
doaj   +1 more source

Success of anti-CD20 monoclonal antibody treatment for severe autoimmune hemolytic anemia caused by warm-reactive immunoglobulin A, immunoglobulin G, and immunoglobulin M autoantibodies in a child: a case report

Journal of Medical Case Reports, 2017
Background Autoimmune hemolytic anemia is rare in children. First-line therapies for this disease consist of corticosteroids and intravenously administered immunoglobulin that are effective in most patients. However, a small proportion of cases (5 to 10%)
Houda Ajmi, Sameh Mabrouk, Saida Hassayoun, Haifa Regaieg, Minyar Tfifha, Chemli Jalel, Hadef Skouri, Noura Zouari, Saoussan Abroug   +8 more
doaj   +1 more source

Severe refractory autoimmune hemolytic anemia with both warm and cold autoantibodies that responded completely to a single cycle of rituximab: a case report

Journal of Medical Case Reports, 2011
Introduction Mixed warm and cold autoimmune hemolytic anemia runs a chronic course with severe intermittent exacerbations. Therapeutic options for the treatment of hemolysis associated with autoimmune hemolytic anemia are limited.
Forte Frank, Gottesman Aaron, Varma Seema, Nakhl Fadi, Szerszen Anita, Gupta Shilpi, Dhar Meekoo   +6 more
doaj   +1 more source

Autoimmune hemolytic anemia

Current Opinion in Immunology, 1994
Autoimmune hemolytic anemia (AHA) is characterized by the production of Coombs' antibodies, which are responsible for the destruction of red blood cells (RBCs). Analysis of both monoclonal anti-RBC autoantibodies derived from autoimmune New Zealand black mice and transgenic mice expressing a pathogenic IgM anti-RBC autoantibody has considerably ...
openaire   +4 more sources